☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
Hyloris
Hyloris Reports Results of Valacyclovir Oral Suspension Under Clinical Evaluation for Herpes Virus Infections
December 27, 2023
Hyloris Entered into an Exclusive License and Distribution Agreement with AFT Pharmaceuticals for Maxigesic IV in 9 EU Countries
January 24, 2023
Load more...
Back to Home
Modal title
×
Modal body text goes here.
